André Koch

No ORCID on file · 14 papers in corpus · active 2020-2026

Study types

  • article 8
  • dataset 2
  • other 2

Condition tags

  • endometriosis 1
article 2026
Additional file 1 of NMR-based serum metabolite and lipoprotein profiling for endometriosis across clinically relevant and physiological comparator settings: assessment of diagnostic utility and exploratory biological signals
·doi:10.6084/m9.figshare.32723643.v1

Supplementary Material 1: Table S1. Table S1 – Annotation of the abbreviations used by the IVDr lipoprotein profiling analysis.

article 2026
Additional file 1 of NMR-based serum metabolite and lipoprotein profiling for endometriosis across clinically relevant and physiological comparator settings: assessment of diagnostic utility and exploratory biological signals
·doi:10.6084/m9.figshare.32723643

Supplementary Material 1: Table S1. Table S1 – Annotation of the abbreviations used by the IVDr lipoprotein profiling analysis.

dataset 2026
Additional file 2 of NMR-based serum metabolite and lipoprotein profiling for endometriosis across clinically relevant and physiological comparator settings: assessment of diagnostic utility and exploratory biological signals
·doi:10.6084/m9.figshare.32723646.v1

Supplementary Material 2: Tables S2-S3. Table S2 – Assay-specific lower limits of quantitation (LLOQ, pg/mL) used to define missing cytokine values. Table S3 – Membership of non-grey WGCNA modules identified in the signed network analysis.

dataset 2026
Additional file 2 of NMR-based serum metabolite and lipoprotein profiling for endometriosis across clinically relevant and physiological comparator settings: assessment of diagnostic utility and exploratory biological signals
·doi:10.6084/m9.figshare.32723646

Supplementary Material 2: Tables S2-S3. Table S2 – Assay-specific lower limits of quantitation (LLOQ, pg/mL) used to define missing cytokine values. Table S3 – Membership of non-grey WGCNA modules identified in the signed network analysis.

article 2026
Additional file 4 of NMR-based serum metabolite and lipoprotein profiling for endometriosis across clinically relevant and physiological comparator settings: assessment of diagnostic utility and exploratory biological signals
·doi:10.6084/m9.figshare.32723652.v1

Supplementary Material 4: Table S4A. Table S4A – Exploratory nominal cytokine-metabolite and cytokine-lipoprotein associations (Spearman raw p < 0.05) in the endometriosis-only and sensitivity cohorts.

article 2026
Additional file 4 of NMR-based serum metabolite and lipoprotein profiling for endometriosis across clinically relevant and physiological comparator settings: assessment of diagnostic utility and exploratory biological signals
·doi:10.6084/m9.figshare.32723652

Supplementary Material 4: Table S4A. Table S4A – Exploratory nominal cytokine-metabolite and cytokine-lipoprotein associations (Spearman raw p < 0.05) in the endometriosis-only and sensitivity cohorts.

article 2026
Additional file 5 of NMR-based serum metabolite and lipoprotein profiling for endometriosis across clinically relevant and physiological comparator settings: assessment of diagnostic utility and exploratory biological signals
·doi:10.6084/m9.figshare.32723655

Supplementary Material 5: Table S4B. Table S4B – FDR-significant cytokine-cytokine correlations in the endometriosis-only and sensitivity cohorts.

article 2026
Additional file 5 of NMR-based serum metabolite and lipoprotein profiling for endometriosis across clinically relevant and physiological comparator settings: assessment of diagnostic utility and exploratory biological signals
·doi:10.6084/m9.figshare.32723655.v1

Supplementary Material 5: Table S4B. Table S4B – FDR-significant cytokine-cytokine correlations in the endometriosis-only and sensitivity cohorts.

other 2026
NMR-based serum metabolite and lipoprotein profiling for endometriosis across clinically relevant and physiological comparator settings: assessment of diagnostic utility and exploratory biological signals
·doi:10.6084/m9.figshare.c.8544015

Abstract Background Reliable non-invasive biomarkers for endometriosis remain unavailable in routine practice, and their translational value depends on performance in symptomatic referral populations rather than only against healthy control…

article 2026
NMR-based serum metabolite and lipoprotein profiling for endometriosis across clinically relevant and physiological comparator settings: assessment of diagnostic utility and exploratory biological signals
BMC medicine ·doi:10.1186/s12916-026-04999-2

BACKGROUND: Reliable non-invasive biomarkers for endometriosis remain unavailable in routine practice, and their translational value depends on performance in symptomatic referral populations rather than only against healthy controls. We ev…

other 2026
NMR-based serum metabolite and lipoprotein profiling for endometriosis across clinically relevant and physiological comparator settings: assessment of diagnostic utility and exploratory biological signals
·doi:10.6084/m9.figshare.c.8544015.v1

Abstract Background Reliable non-invasive biomarkers for endometriosis remain unavailable in routine practice, and their translational value depends on performance in symptomatic referral populations rather than only against healthy control…

2024
A Cohort of 469 Mayer-Rokitansky-Küster-Hauser Syndrome Patients-Associated Malformations, Syndromes, and Heterogeneity of the Phenotype.
Journal of clinical medicine ·doi:10.3390/jcm13020607

The Mayer-Rokitansky-Küster-Hauser syndrome is characterized by aplasia of the uterus and upper two-thirds of the vagina. While it can appear as an isolated genital malformation, it is often associated with extragenital abnormalities, with …

article 2022
Endometriosis in Patients with Mayer-Rokitansky-Küster-Hauser-Syndrome-Histological Evaluation of Uterus Remnants and Peritoneal Lesions and Comparison to Samples from Endometriosis Patients without Mullerian Anomaly
Journal of clinical medicine ·doi:10.3390/jcm11216458

Congenital Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome is a Mullerian-duct anomaly that is characterized by agenesis of the uterus and upper part of the vagina. Uterus remnants of varying sizes can often be found. Although a functional u…

2020
The Endometrial Transcription Landscape of MRKH Syndrome.
Frontiers in cell and developmental biology ·doi:10.3389/fcell.2020.572281

The Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome (OMIM 277000) is characterized by agenesis of the uterus and upper part of the vagina in females with normal ovarian function. While genetic causes have been identified for a small subset o…